MissionIR's  Instablog

Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
My blog:
MissionIR Blog
  • Actinium Pharmaceuticals, Inc. (ATNM) Report Annual Shareholder Meeting's Voting Results And Strong Participation 0 comments
    Dec 30, 2013 2:26 PM | about stocks: ATNM

    Actinium Pharmaceuticals, a biopharmaceutical company with a proprietary platform that combines the precision targeting of monoclonal antibodies with the killing power of alpha and beta radioisotopes, today reported the voting results from its annual general meeting of shareholders (the "meeting") which was held last Monday.

    Holders of approximately 80 percent, or 18.3 million, of Actinium Pharmaceuticals' outstanding shares as of the record date November 7, 2013, participated in the voting at the meeting. According to today's press release, all of the proposed resolutions were approved and ratified including Proposal 1 which showed unanimous support for the Board of Directors.

    Commenting on the results of the meeting, Mr. Sandesh Seth, Chairman of the Board of Actinium Pharmaceuticals, stated, "We are thankful that our shareholders took the time to show their support for the Company and its Board of Directors by voting in such large numbers. We will strive to meet their expectations as we steer the Company from a strategic perspective and work with Management to assure implementation of these strategies as Actinium progresses its lead drug candidates Iomab™-B and Actimab-A in their planned Phase 3 and ongoing Phase 1/2 trials, respectively."

    Dr. Kaushik J. Dave, President and CEO of Actinium Pharmaceuticals, added, "We are pleased that so many of our shareholders were able to participate in the Company's annual general meeting by casting their votes on these important proposals. We express our thanks to them in supporting further efforts by Actinium's Board of Directors and its Management to continue implementing our given strategies to move the Company forward for the benefit of all stockholders."

    For more information on Actinium Pharmaceuticals, visit actiniumpharmaceuticals.com

    MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.missionir.com

    Stocks: ATNM
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.